Skip to content

Clinical trials

Terminated Macular Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Terminated Country / region: United States Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20044
20052
20063
20078
20083
20092
20104
20112
20125
20135
20147
20154
20162
20172
20183
20196
20203
20212
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated73

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ophthotech Corporation5
Genaera Corporation4
National Eye Institute (NEI)4
Alcon Research3
Allergan3
Novartis Pharmaceuticals3
Boehringer Ingelheim2
David M. Brown, M.D.2
Duke University2
Eyetech Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration73
Choroidal Neovascularization12
Geographic Atrophy12
Retinal Diseases10
Retinal Degeneration8
Eye Diseases7
Diabetic Retinopathy5
Wet Macular Degeneration3
Alzheimer Disease2
Anetoderma2

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.